LLMpediaThe first transparent, open encyclopedia generated by LLMs

CARDIAC Risk in the Young

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 65 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted65
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
CARDIAC Risk in the Young
NameCARDIAC Risk in the Young
FieldCardiology
SymptomsSyncope; chest pain; palpitations; sudden collapse
ComplicationsSudden cardiac death; heart failure; neurocognitive injury
OnsetChildhood, adolescence, young adulthood
DurationAcute, chronic
CausesGenetic cardiomyopathies; congenital coronary anomalies; ion channelopathies; myocarditis
DiagnosisElectrocardiogram; echocardiography; cardiac MRI; genetic testing
TreatmentMedical therapy; implantable cardioverter-defibrillator; surgical correction; lifestyle modification

CARDIAC Risk in the Young is the study and clinical concern for cardiovascular conditions that predispose children, adolescents, and young adults to syncope, arrhythmia, and sudden cardiac death. It encompasses inherited disorders, congenital anomalies, acquired inflammatory diseases, and exertional conditions that present across pediatric and young-adult populations. Recognition involves multidisciplinary input from pediatric cardiology, sports medicine, genetics, and emergency medicine.

Introduction

Young persons with elevated cardiac risk include athletes, students, and military recruits evaluated by specialists from American Heart Association guidelines to national screening programs like those associated with National Collegiate Athletic Association and United States Armed Forces. High-profile cases involving figures such as celebrity sudden deaths have driven public interest alongside historic research by groups at institutions including Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, and Great Ormond Street Hospital. Professional societies such as the European Society of Cardiology, American Academy of Pediatrics, American College of Cardiology, and World Health Organization influence policy and practice.

Epidemiology and Risk Factors

Epidemiologic estimates derive from population data collected by registries like the Sudden Death in the Young (SDY) Case Registry and large cohorts studied at centers such as Boston Children's Hospital and Toronto General Hospital. Incidence of sudden cardiac death in young people varies by region—reported by researchers from Sweden and Italy—and is influenced by diverse risk factors including family history of sudden death (noted in pedigrees studied by Framingham Heart Study investigators), known genetic syndromes described at Broad Institute and Wellcome Sanger Institute, participation in competitive sport as regulated by NCAA, and certain infections tracked by Centers for Disease Control and Prevention. Socioeconomic and demographic contributors appear in analyses conducted by Harvard Medical School and public-health units in New York City and Los Angeles County.

Pathophysiology and Common Causes

Major mechanistic categories include structural cardiomyopathies such as hypertrophic cardiomyopathy first described in classical autopsies and contemporary series from Mount Sinai Health System and Stanford University School of Medicine; arrhythmogenic right ventricular cardiomyopathy studied extensively in cohorts from Padua and Netherlands Heart Institute; congenital anomalies of coronary arteries reported by surgical teams at Texas Children's Hospital; and ion-channelopathies including long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia characterized by gene discoveries from Howard Hughes Medical Institute-funded laboratories and consortia like those at University College London. Infectious myocarditis linked to enteroviruses and immune-mediated processes has been documented in case series from Karolinska Institutet and Imperial College London. Trauma-related commotio cordis is reported in sports venues monitored by International Olympic Committee and national federations.

Clinical Presentation and Diagnosis

Presentation ranges from exertional syncope described in athletic medical exams at FIFA and USA Basketball trials to palpitations prompting evaluation at emergency departments in centers such as Massachusetts General Hospital. Diagnostic algorithms incorporate electrocardiography used in guidelines by AHA and ESC, echocardiography practiced at Boston Children's Hospital, ambulatory Holter monitoring used in studies from Johns Hopkins University School of Medicine, cardiac magnetic resonance imaging protocols developed at Mayo Clinic, exercise stress testing used by U.S. Olympic Committee clinicians, and genetic testing pipelines run by facilities including GeneDx and Invitae. Specialist input from electrophysiologists at Cleveland Clinic and pediatric cardiologists at Great Ormond Street Hospital guides interpretation of variants cataloged in resources like ClinVar.

Screening, Prevention, and Risk Stratification

Screening approaches debated by panels convened by AHA, ESC, IOC Medical Commission, NCAA, and national ministries of health include history and physical examination, 12-lead ECG, and targeted echocardiography. Risk stratification models are informed by cohort studies from Olmsted County and multicenter registries coordinated with European Reference Networks and national registries in Japan and Australia. Preventive measures span counseling from specialists at Johns Hopkins Hospital, tailored exercise recommendations used by Stanford Sports Cardiology Program, vaccination programs promoted by CDC to reduce myocarditis risk, and cascade genetic screening implemented by genetics services at Mount Sinai and Molecular Genetics Laboratories.

Management and Treatment

Acute management for life-threatening arrhythmia follows protocols established by American Heart Association and European Resuscitation Council, including cardiopulmonary resuscitation and automated external defibrillators deployed per American Red Cross guidance. Long-term therapy includes pharmacologic agents such as beta-blockers prescribed in clinics at Mayo Clinic; implantable cardioverter-defibrillators placed by electrophysiology teams at Cleveland Clinic and Mount Sinai; surgical interventions for coronary anomalies performed at Texas Children's Hospital and Great Ormond Street Hospital; and catheter ablation techniques refined at Massachusetts General Hospital. Multidisciplinary care integrates sports cardiology clinics affiliated with Stanford University, mental-health support from services at Royal Children’s Hospital Melbourne, and reproductive counseling provided by departments at UCSF Medical Center.

Prognosis and Long-term Outcomes

Outcomes depend on cause, age at presentation, and access to specialized care documented in longitudinal studies from Framingham Heart Study-derived analyses, registries at Nationwide Children’s Hospital, and multicenter trials coordinated by European Society of Cardiology investigators. Survivors of cardiac arrest managed by programs at Resuscitation Academy and rehabilitation services at Mayo Clinic may face variable risks of recurrence, exercise limitations, and psychosocial effects studied by teams at Harvard Medical School and University of Toronto. Lifelong follow-up in clinics such as those at Great Ormond Street Hospital and Boston Children’s Hospital supports transition to adult services overseen by specialists at Johns Hopkins and Cleveland Clinic.

Category:Cardiology